The pharmaceutical industry is increasingly turning to incentive programs as a solution to persistent clinical trial enrollment and engagement challenges. According to BioPharma Dive, the right incentive structure can significantly boost both patient recruitment and sustained participation throughout study periods.
Clinical trial enrollment has long been a bottleneck in drug development, with many studies failing to meet recruitment targets within projected timelines. Patient retention through lengthy trial protocols presents additional complications that can compromise study integrity and delay regulatory submissions.